Volition

We can't wait to meet you at #AVMA2025 this weekend! Stop by booth 1441 to hear the latest updates on Nu.Q® Vet, our simple blood test to aid early detection of cancer in dogs. #VetMed #CanineCancer

NEWS: Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation. Read more in our press release: tinyurl.com/yck5rpmn

Curious about utilising the Nu.Q® Vet Cancer Test in your practice? Join our free webinar TOMORROW for practical tips, case studies, and more! 📅 July 16 ⌚ 8pm BST/3pm ET/12 noon PT 🔗 Register here: tinyurl.com/nhabdze6 #VetWebinar #VeterinaryMedicine #CanineCancer

In our new paper, published in @jbiolchem, we aim to inform about our Nu.Q® immunoassays, which can be applied at all stages of drug development, from cell models to patient blood samples. Download: tinyurl.com/yc69thh3

Curious about utilising the Nu.Q® Vet Cancer Test in your practice? Join our free webinar for practical tips, case studies, and more! 📅 July 16 ⌚ 8pm BST/3pm ET/12 noon PT 🔗 Register here: tinyurl.com/nhabdze6 #VetWebinar #VeterinaryMedicine #CanineCancer

NEWS: Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes Read the press release: tinyurl.com/2bwf3fcm

VolitionRx — Nu.Q advances in lung cancer management. $VNRX #NYSE @VolitionRx edisongroup.com/research/nu-q-…

Join our poster presentation at #ISTH2025 today: ⌚1:45 PM - 2:45 PM EDT Poster number: PB1615

New MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure. Learn more in our press release: tinyurl.com/3nmhvdc6

Volition announces two oral presentations at the Asian Meeting of Animal Medicine Specialties, highlighting advances in veterinary diagnostics. Find out more: tinyurl.com/3w2tjjy2

32% of adults in Northern Ireland say they confidently know what sepsis is. A new YouGov survey commissioned by Sepsis Research FEAT reveals widespread gaps in awareness — especially among younger adults and men.

This Intensive Care Week, we’re shining a light on the people, progress, and possibilities behind #criticalcare. We sat down with our Chief Medical Officer, Dr. Andrew Retter, to discuss the evolution of intensive care, from the pressures of the pandemic to the promise of AI and…

On-Demand Webinar: Early Detection with Canine Cancer Screening 🐶 Explore the challenges and unmet needs in diagnosing canine cancer with insights from Dr. Sue Ettinger (aka @DrSueCancerVet) — a leading expert in veterinary oncology. This RACE-approved webinar covers: ✅…

Meet our Chief Operating Officer, Gaetan! Gaetan has been with Volition for 10+ years, expanding operations not only in Europe, but also in the U.S. Find out more: tinyurl.com/4fd7az8y

Some Nu.Q® Vet Cancer Test questions we get asked often, answered by Dr. Lisa Lippman! Find out more on our website: tinyurl.com/3vkenb6w

Nu.Q® Discover is a valuable research tool to support your drug discovery and development need, from target identification to validation, in clinical studies. Find out more: tinyurl.com/495heavk

Explore how epigenetics is transforming lung cancer diagnostics, offering earlier detection, greater precision, and renewed hope. Read how Volition's technology is lighting the way forward in #LungCancer detection: tinyurl.com/ydj5deyf #LungCancerAwareness #Epigenetics

NEWS: VolitionRx has published the first study to report the detection of nucleosomes in cats. Read our press release for more information: tinyurl.com/y4u4hyc8 #FelineCancer #Epigenetics

We have just announced our Q1 2025 financial results and business update. Join our conference call tomorrow at 8:30 a.m. ET to find out more. Read our press release: tinyurl.com/2ucvkm8w

We received the Young Investigator Bronze Award for our 'Advances in Liquid Biopsy for Glioblastoma Diagnosis and Monitoring through Nucleosome Epigenetic Modifications Tracking' poster at #ISMRC2025! View the posters presented: tinyurl.com/mydmnhja tinyurl.com/sf799acf